I. Moldovan et al., Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions, IMMUNOL LET, 68(1), 1999, pp. 125-134
CD16 (Fc gamma R type III), a low affinity IgG Fc receptor, is found in two
forms, a transmembrane Fc gamma RIIIa expressed by NK cells and monocytes
and a phosphatidylinositol-linked Fc gamma RIIIb present on neutrophils. Ex
posure of neutrophils to inflammatory signals induces a rapid loss of CD16
expression and release of a soluble form of CD16 (sCD16). Soluble CD16 circ
ulates in plasma, levels being reduced in sera from patients with multiple
myeloma. In the present manuscript the authors summarize work that aimed to
better understand: (i) the role of proteinases in sCD16 production and CD1
6 membrane shedding; and (ii) the regulation of sCD16 levels in multiple my
eloma patients and the possible biological consequences of its decrease in
this disease. Soluble CD16 was purified from human serum. Its N-terminal se
quencing demonstrated that it originates from neutrophil CD16 and its C-ter
minal sequencing showed that the cleavage site was between Val 196 and Ser
197, close to the membrane anchor. Analysis of the effect of protease inhib
itors revealed that the cleavage leading to sCD16 production by PMA-activat
ed neutrophils was metalloproteinase-dependent. In addition, membrane and s
CD16 were sensitive to serine proteinases released by azurophil granules or
added under purified form. The reduction of sCD16 levels that occurs in pa
tients with multiple myeloma was associated with a slight decrease in circu
lating neutrophils, but not with a significant defect in sCD16 production b
y neutrophils, as detected in vitro. Moreover, addition of a recombinant sC
D16 to plasmocytoma lines did not significantly modify their proliferation
and Ig secretion. (C) 1999 Elsevier Science B.V. All rights reserved.